BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28279929)

  • 1. Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimens.
    Chen Y; Harrington BS; Lau KCN; Burke LJ; He Y; Iconomou M; Palmer JS; Meade B; Lumley JW; Hooper JD
    J Pharm Biomed Anal; 2017 May; 139():65-72. PubMed ID: 28279929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1.
    He Y; Reid JC; He H; Harrington BS; Finlayson B; Khan T; Hooper JD
    Biol Chem; 2018 Sep; 399(9):1091-1097. PubMed ID: 29447112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
    Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
    Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.
    He Y; Wortmann A; Burke LJ; Reid JC; Adams MN; Abdul-Jabbar I; Quigley JP; Leduc R; Kirchhofer D; Hooper JD
    J Biol Chem; 2010 Aug; 285(34):26162-73. PubMed ID: 20551327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
    Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
    Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
    Harrington BS; He Y; Davies CM; Wallace SJ; Adams MN; Beaven EA; Roche DK; Kennedy C; Chetty NP; Crandon AJ; Flatley C; Oliveira NB; Shannon CM; deFazio A; Tinker AV; Gilks CB; Gabrielli B; Brennan DJ; Coward JI; Armes JE; Perrin LC; Hooper JD
    Br J Cancer; 2016 Feb; 114(4):417-26. PubMed ID: 26882065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.
    Yang L; Dutta SM; Troyer DA; Lin JB; Lance RA; Nyalwidhe JO; Drake RR; Semmes OJ
    Oncotarget; 2015 Dec; 6(41):43743-58. PubMed ID: 26497208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
    Johdi NA; Mazlan L; Sagap I; Jamal R
    Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of the CDCP1 protein in human cord plasma may serve as a predictor of hematopoietic stem and progenitor cell content.
    Frändberg S; Asp J; Waldner B; Holgersson J; Palmqvist L
    Stem Cell Res; 2018 May; 29():24-27. PubMed ID: 29574172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUB domain containing protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells.
    Orchard-Webb DJ; Lee TC; Cook GP; Blair GE
    BMC Cancer; 2014 Oct; 14():754. PubMed ID: 25301083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells.
    Perry SE; Robinson P; Melcher A; Quirke P; Bühring HJ; Cook GP; Blair GE
    FEBS Lett; 2007 Mar; 581(6):1137-42. PubMed ID: 17335815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.
    Deryugina EI; Conn EM; Wortmann A; Partridge JJ; Kupriyanova TA; Ardi VC; Hooper JD; Quigley JP
    Mol Cancer Res; 2009 Aug; 7(8):1197-211. PubMed ID: 19671673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.
    Gandji LY; Proust R; Larue L; Gesbert F
    PLoS One; 2015; 10(4):e0123472. PubMed ID: 25876044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
    Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
    Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.
    Chiang SF; Kan CY; Hsiao YC; Tang R; Hsieh LL; Chiang JM; Tsai WS; Yeh CY; Hsieh PS; Liang Y; Chen JS; Yu JS
    Dis Markers; 2015; 2015():874054. PubMed ID: 26494939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
    Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
    Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
    Kollmorgen G; Niederfellner G; Lifke A; Spohn GJ; Rieder N; Harring SV; Bauss F; Burtscher H; Lammers R; Bossenmaier B
    Mol Oncol; 2013 Dec; 7(6):1142-51. PubMed ID: 24055141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.
    Vaisocherová H; Faca VM; Taylor AD; Hanash S; Jiang S
    Biosens Bioelectron; 2009 Mar; 24(7):2143-8. PubMed ID: 19157844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of serum CEACAM1 as a potential biomarker for breast cancer.
    Yang C; He P; Liu Y; He Y; Yang C; Du Y; Zhou M; Wang W; Zhang G; Wu M; Gao F
    Clin Chim Acta; 2015 Oct; 450():277-81. PubMed ID: 26343926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.